# Agios Pharmaceuticals, Inc.: Form 4, filed Oct 23, 2026

- Company: [Agios Pharmaceuticals, Inc.](/companies/agio.md) (CIK 1439222)
- Form: 4
- Filed: 2026-10-23
- Accepted by EDGAR: Oct 23, 2026, 16:05 ET
- Period: 2026-10-21
- Accession: 0001439222-26-000122
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1439222/000143922226000122/xslF345X06/wk-form4_1792785942.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439222/000143922226000122/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439222/000143922226000122/xslF345X06/wk-form4_1792785942.xml

Filed Oct 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001439222-26-000122. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
